v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Apr. 30, 2025
Apr. 30, 2024
Current assets    
Cash and cash equivalents $ 237,595 $ 8,249
Accounts receivable, net 8,081 1,998
Disposable medical equipment supplies 6,572 3,290
Prepaid expenses and other current assets 3,080 1,370
Total current assets 255,328 14,907
Right-of-use assets 2,078 2,286
Deposits 2,021 1,710
Restricted cash 334 334
Property and equipment, net 34,830 26,105
Other long-term assets 1,153 607
Total assets 295,744 45,949
Current liabilities    
Accounts payable 23,961 23,892
Accrued liabilities 13,829 9,079
Operating lease liabilities, current portion 187  
Total current liabilities 37,977 32,971
Operating lease liabilities, net of current portion 3,026 2,633
Warrant liabilities 8,097  
Other long-term liabilities 140 76
Long-term debt, net 41,098 42,536
Total liabilities 90,338 78,216
Commitments and contingencies (Note 14)
Redeemable preferred stock, $0.01 par value; 0 and 5,000,000 shares authorized as of April 30, 2025 and April 30, 2024, respectively; 0 and 177,110 shares issued and outstanding as of April 30, 2025 and April 30, 2024, respectively   177,110
Stockholders' equity (deficit)    
Common stock, $0.01 par value; 5,000,000 shares authorized as of April 30, 2024; 105,808 shares issued and outstanding as of April 30, 2024. Common shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2025; 51,348,656 shares issued and outstanding as of April 30, 2025 51,349 19,909
Additional paid-in capital 674,306 177,149
Accumulated deficit (520,249) (406,435)
Total shareholders' equity (deficit) 205,406 (209,377)
Total liabilities and shareholders' equity (deficit) $ 295,744 $ 45,949